Pharmaceutical Research

, Volume 25, Issue 4, pp 781–791

Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control

Authors

    • Food and Drug AdministrationOffice of Generic Drugs
Research Paper

DOI: 10.1007/s11095-007-9511-1

Cite this article as:
Yu, L.X. Pharm Res (2008) 25: 781. doi:10.1007/s11095-007-9511-1

Abstract

Purpose

The purpose of this paper is to discuss the pharmaceutical Quality by Design (QbD) and describe how it can be used to ensure pharmaceutical quality.

Materials and Methods

The QbD was described and some of its elements identified. Process parameters and quality attributes were identified for each unit operation during manufacture of solid oral dosage forms. The use of QbD was contrasted with the evaluation of product quality by testing alone.

Results

The QbD is a systemic approach to pharmaceutical development. It means designing and developing formulations and manufacturing processes to ensure predefined product quality. Some of the QbD elements include:
  • Defining target product quality profile

  • Designing product and manufacturing processes

  • Identifying critical quality attributes, process parameters, and sources of variability

  • Controlling manufacturing processes to produce consistent quality over time

Conclusions

Using QbD, pharmaceutical quality is assured by understanding and controlling formulation and manufacturing variables. Product testing confirms the product quality. Implementation of QbD will enable transformation of the chemistry, manufacturing, and controls (CMC) review of abbreviated new drug applications (ANDAs) into a science-based pharmaceutical quality assessment.

Key Words

pharmaceutical quality by designpharmaceutical quality by testingprocess controlprocess designprocess parameterprocess variabilityproduct designquality attributequestion-based review

Copyright information

© US Government: Food and Drug Administration 2007